Deka Bank Deutsche Girozentrale Inovio Pharmaceuticals, Inc. Transaction History

Deka Bank Deutsche Girozentrale

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	BUY	$2.97 - $5.2 $16,632 - $29,120	5,600 Added 10.09%	61,100 $223,000
Q4 2021 Feb 02, 2022	BUY	$4.99 - $7.46 $7,485 - $11,190	1,500 Added 2.78%	55,500 $285,000
Q4 2020 Mar 12, 2021	SELL	$8.5 - $12.85 $21,250 - $32,125	-2,500 Reduced 4.42%	54,000 $478,000
Q3 2020 Oct 29, 2020	BUY	$9.57 - $27.05 $540,705 - $1.53 Million	56,500 New	56,500 $633,000
Q4 2019 Feb 04, 2020	SELL	$1.97 - $3.72 $58,903 - $111,228	-29,900 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.05 - $3.02 $61,294 - $90,298	-29,900 Reduced 50.0%	29,900 $63,000
Q2 2019 Aug 01, 2019	BUY	$2.29 - $4.1 $53,586 - $95,939	23,400 Added 64.29%	59,800 $175,000
Q1 2019 May 10, 2019	BUY	$3.34 - $5.1 $21,710 - $33,150	6,500 Added 21.74%	36,400 $184,000
Q4 2018 Feb 12, 2019	SELL	$3.89 - $6.11 $25,285 - $39,715	-6,500 Reduced 17.86%	29,900 $118,000
Q3 2018 Nov 09, 2018	SELL	$3.92 - $5.58 $3,920 - $5,580	-1,000 Reduced 2.67%	36,400 $0
Q1 2018 May 03, 2018	SELL	$4.05 - $5.69 $14,580 - $20,484	-3,600 Reduced 8.78%	37,400 $176,000
Q3 2017 Nov 06, 2017	BUY	$5.36 - $6.37 $219,760 - $261,170	41,000	41,000 $226,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $486M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.